Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging
PR Newswire•24/09/2026•08:00 ET
0
Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging PR Newswire
Panel at Harvard University will explore translating evidence in diseases of aging into new therapeutics and regulatory pathways
Get started
Create a free account to read the full story and Whiz Insights.